HPP acted as the legal advisor of the seller in a transaction whereby Genetricum Ltd. sold the shares in DRA Consulting Oy to Pharmalex Nordic ApS, a company belonging to the PharmaLex group.
DRA Consulting Oy provides expert services for companies who manufacture and sell medicine and health technology products. DRA Consulting Oy is a partner of more than 300 pharmaceutical and health technology companies across Europe. The transaction offers DRA Consulting Oy a significant role in PharmaLex’s Nordic organisation, which has previously lacked a partner with expertise in the Finnish market.
